Neil Harris Blumenthal

Co-CEO Neil Harris Blumenthal sold 217,667 shares of WRBY at $29.61 on 2026-07-01 under pre-arranged 10b5-1 plan; retains 31,112 shares plus derivative holdings.

Neil Harris Blumenthal executed a scheduled sale of 217,667 shares for $6,445,119.87 under a pre-arranged 10b5-1 trading plan adopted on 2026-03-17, reducing his non-derivative holdings by 87.5% to 31,112 shares while retaining 3,229,650 shares in Class B Common Stock. The sale price of $29.61 is -5.6% from the 52-week high of $31.00, occurring after a 30-day +16.6% rally and 90-day +44.2% gain in the stock. Across his cross-ticker track record, his prior 20 open-market sells averaged -3.3% returns over 30 days and -17.2% over 90 days; at WRBY specifically, his five prior sales showed mixed near-term outcomes ranging from -13.6% to +19.3% over 30 days. Given the 10b5-1 structure, this transaction is scheduled rather than discretionary, and the insider retains substantial derivative holdings alongside the reduced non-derivative position.

WRBY co-CEO Blumenthal sells 36.3K shares at $30.04 under scheduled 10b5-1 plan; retains 59.5K non-derivative shares

Neil Harris Blumenthal, Co-Chief Executive Officer, sold 36,300 shares of WRBY at $30.04 on 2026-06-29 for $1,090,452.00 as part of a pre-arranged 10b5-1 trading plan adopted on 2025-09-16—a scheduled transaction, not a discretionary action. His post-transaction non-derivative holdings stand at 59,459 shares, down 37.9% from the 95,759 shares held before this sale. The stock currently trades at $29.37, down 5.3% from its 52-week high of $31.00, though it is up 20.5% over the past 30 days and +44.8% over 90 days. Across his cross-ticker track record, his prior 20 open-market sells averaged -3.3% 30-day returns and -17.2% 90-day returns; his same-ticker history at WRBY shows mixed recent outcomes, with one May 2026 sale down 13.6% at 30 days and earlier April sales posting gains of 14.7%, 18.3%, and 19.3% at 30 days.

Neil Harris Blumenthal (Co-CEO) sold 63,040 shares of WRBY at $30.03 under pre-arranged 10b5-1 plan; stock now $24.50.

Neil Harris Blumenthal sold 63,040 shares (-55.7% vs pre-transaction holdings) on 2026-05-19 at $30.03 under a pre-arranged 10b5-1 trading plan adopted on 2025-09-16, making this a scheduled transaction rather than a discretionary choice. The current price of $24.50 is -21.0% from the 52-week high of $31.00, and the stock is down 2.6% over 30 days. Across his cross-ticker track record, his prior 20 sells averaged -2.7% return over 30 days and -14.5% over 90 days, while at WRBY specifically his 5 prior trades showed mixed near-term performance ranging from -5.8% to +19.3% at 30 days. The company reports $242.4M revenue in the latest quarter with +13.0% annual growth, but carries a P/E of 2450.00 on net income of $3.2M, signaling thin profitability relative to valuation.

WRBY Co-CEO Blumenthal sells 100,000 shares for $2.5M via scheduled 10b5-1 plan (Apr 16-20)

Co-Chief Executive Officer Neil Harris Blumenthal executed 4 separate sales totaling 100,000 shares for $2,467,129.65 between April 16 and April 20, 2026, at prices ranging from $24.08 to $25.09 per share, consistent with a pre-arranged 10b5-1 trading plan adopted on September 16, 2025. This represents a -66.6% reduction in his shareholdings, from 150,165 to 50,165 shares post-transaction. Since the sales were executed pursuant to a scheduled 10b5-1 plan rather than a discretionary decision, they do not convey timing or conviction-based signals. The sale is material in absolute terms given the 100.0K shares and $2.5M aggregate value, but investors should note that a substantial derivative position in Table II—not yet populated in the database—may represent additional economic interest and should be reviewed to assess the insider's full stake.

Co-CEO Blumenthal sold 50,000 WRBY shares at $27.08 on 2026-01-07; post-sale holdings 37,119 shares (-57.4% reduction).

Blumenthal sold 50,000 shares of Warby Parker at $27.08, reducing his holdings by 57.4% from 87,119 to 37,119 shares in a single transaction worth $1,354,000.00. This follows a pattern of four recent sells at the same ticker on 2026-01-06 and 2025-12-11, with only one prior measurable outcome at WRBY (a 2025-09-11 sale that showed +7.4% 90-day return, indicating the stock rose after sale). At the broader cross-ticker level, the insider's 20 prior sells averaged +0.8% over 90 days with a 68.75% well-timed rate, suggesting his sales have historically preceded modest gains rather than declines. The company's current valuation (P/E of 2830.00) reflects very limited profitability; Q4 revenue of $221.7M yielded only $5.9M net income, and the full fiscal year was unprofitable. The stock is trading 6.4% below its 52-week high and down 4.3% over 30 days despite a 27.1% 90-day gain.

Co-CEO Neil Blumenthal sold 150,000 shares at $24.29–$25.99 for $3,763,500 under pre-arranged 10b5-1 plan

Neil Blumenthal, Co-Chief Executive Officer of Warby Parker, executed 3 separate sales totaling 150,000 shares (150.0K shares) for $3,763,500.00 on 2026-01-06 at prices ranging from $24.29 to $25.99, with a blended average price of $25.09. His holdings declined from 187,119 shares to 37,119 shares, a reduction of 80.2% of pre-transaction holdings. This sale was conducted under a 10b5-1 trading plan adopted on 2025-09-16, meaning the transaction was scheduled and pre-arranged rather than discretionary. The filing contains derivative securities that are not yet fully reflected in the database, so the shares_after figure does not capture the insider's complete position including derivative conversions.

Co-CEO Blumenthal sells 100,000 WRBY shares at $30.29 under pre-arranged 10b5-1 plan; 37.1K shares remain.

Co-Chief Executive Officer Neil Harris Blumenthal sold 100,000 shares of Warby Parker for $3.0M on 2025-12-11, reducing his direct holdings from 137.1K to 37.1K shares. The sale was executed under a pre-arranged 10b5-1 trading plan adopted on 2025-03-14, making it a scheduled transaction rather than a discretionary decision. The filing flags a derivative-conversion transaction, indicating that Table II derivative securities may contain additional position data not yet populated in this database, so the 37.1K post-transaction figure reflects only Form 4 Table I holdings. This represents a material reduction in the co-CEO's direct equity stake in the company, though the scheduled nature of the trade through a 10b5-1 plan limits inference about current conviction or near-term stock outlook.

Co-CEO Blumenthal sells 41,084 WRBY shares at $27.53; retains 32,733 post-transaction following derivative conversion.

Blumenthal sold 41,084 shares (41.1K shares) at $27.53 on 2025-09-11 for $1,131,042.52 ($1.1M), reducing his holdings from 73,817 to 32,733 shares (-55.7% vs pre-transaction holdings). This sale occurred as part of a derivative-conversion transaction, meaning the insider's full economic position extends beyond the Table I shares reported here. At his prior WRBY sales on 2025-08-13, 2025-07-21, and 2025-07-18, the stock subsequently rose by +6.5%, +9.7%, and +13.0% over 30 days respectively—indicating that his recent transaction pattern at this ticker has been poorly timed. The company reported revenue of $214,475,000.00 ($214.5M) in the latest quarter but posted a net loss of $-1,752,000.00 ($-1.8M), with annual revenue growth of +15.2% despite remaining unprofitable over its most recent full fiscal year. The stock currently trades at $26.36, down 7.2% from its 52-week high of $28.42, whereas it traded at $27.53 on the transaction date. An investor should note that this sale is not a full position exit due to the derivative-conversion component; the insider's derivative holdings (Table II) would provide the complete picture of his remaining economic exposure.

Co-CEO Blumenthal sells 50,000 WRBY shares ($1.3M) at $25.11; retains 28,347 shares. Prior WRBY sales 90d well-timed; stock up 52.6% in 90 days.

Blumenthal sold 50,000 shares ($1.3M) on 2025-08-13 at $25.11, reducing his holdings from 78,347 to 28,347 shares. His prior three sales at Warby Parker were well-timed at the 90-day mark (posting -31.5%, -26.6%, and -24.5% respective returns), suggesting consistent ability to identify local peaks; however, the current transaction was executed as the stock entered strong momentum, with a 52.6% 90-day gain and a 16.5% 30-day gain following the sale date. This sale contradicts his own pattern of selling into weakness rather than strength. The company remains unprofitable despite 15.2% annual revenue growth, adding fundamental ambiguity around the valuation at which the sale occurred. A FLAG indicates derivative-conversion activity, meaning his Table I shares_after (28,347) do not represent his complete economic position, limiting the visibility into his net exposure.

WRBY Co-CEO Blumenthal sells 50,000 shares for $1.2M via pre-arranged 10b5-1 plan; retains 28,347 shares

Neil Harris Blumenthal, Co-Chief Executive Officer of Warby Parker Inc., executed 2 separate sales totaling 50,000 shares for $1,210,420.00 under a 10b5-1 trading plan adopted on 2025-03-14, reducing his holdings from 78,347 shares to 28,347 shares. The sales occurred at $24.01 on 2025-07-18 (400 shares) and $24.21 on 2025-07-21 (49,600 shares), with a blended average price of $24.21. Since this transaction is part of a pre-arranged, scheduled trading plan rather than a discretionary decision, the sales reflect execution of a plan established months prior, not a response to current market conditions or company fundamentals. The insider retains a meaningful stake of 28,347 shares post-transaction, indicating continued direct equity interest in the company.